Hu Hong H - OmicsDI

Show results for

Unknown (1880)
Proteomics (55)
Transcriptomics (25)
Metabolomics (12)
Genomics (4)
Models (1)

Organisms

Aerococcus urinae NBRC 15544 = CCUG 36881 (30)
Alteromonadales (30)
Bacteria (30)
Canis lupus familiaris (30)
Carya cathayensis (30)
Ectopseudomonas oleovorans CECT 5344 (30)
Ensifer adhaerens (30)
Enterococcus faecalis (30)
Globicatella sanguinis (30)
Halictus scabiosae (30)
Histomonas meleagridis (30)
Human immunodeficiency virus 1 (30)
Methylohalobius crimeensis 10Ki (30)
Mus musculus (30)
Olavius algarvensis sulfate-reducing endosymbiont (30)
Ophrys garganica (30)
Homo sapiens (24)
Rattus norvegicus (8)
Mus musculus (8)
Camponotus floridanus (2)
Bos taurus (2)
Clostridioides difficile 630 (1)
Acromyrmex echinatior (1)
Harpegnathos saltator (1)
Oryza sativa (1)
Escherichia coli (1)
Mus sp. (1)
Oryctolagus cuniculus (1)
Severe acute respiratory syndrome coronavirus 2 (1)
Drosophila melanogaster (1)

Repository

pride (30)
biostudies-arrayexpress (27)
iProX (21)
MetaboLights (11)
MassIVE (3)
EGA (2)
BioModels (1)
GNPS (1)
jPOST (1)

Tissue

Cell culture (11)
Blood plasma (2)
Embryonic stem cell (2)
Epithelial cell (2)
Mycelial cord (2)
Bile (1)
Blood (1)
Cardiac muscle cell (1)
Colon (1)
Gill (1)
Kidney (1)
Permanent cell line cell (1)
Plant cell (1)
Primary cell (1)
Seed (1)
Skin (1)

Disease

Colon cancer (1)
IgA glomerulonephritis (1)
Malignant neoplasm of ovary (1)
Neuroblastoma (1)

Technology Type

Mass Spectrometry (30)
Shotgun proteomics (17)
Mass spectrometry (9)
Bottom-up proteomics (5)
Gel-based experiment (5)
Affinity purification coupled with mass spectrometry proteomics (3)
Mass spectrometry assay (2)
Chemical cross-linking coupled with mass spectrometry proteomics (2)
Data-dependent acquisition (1)

Instrument Platform

Orbitrap Fusion Lumos (2)
6540 Q-TOF LC/MS (Agilent) (2)
Liquid Chromatography MS - (2)
Liquid Chromatography MS - negative - reverse phase (2)
Liquid Chromatography MS - positive - reverse phase (2)
NextSeq 500 (1)
MicrOTOF-Q II (1)
Q Exactive (1)
Orbitrap Fusion ETD (1)
TSQ Quantum GC (Thermo Scientific) (1)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (1)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (1)
5975C Series GC/MSD (Agilent) (1)
Liquid Chromatography MS - positive - reverse-phase (1)
Liquid Chromatography MS - negative - reverse-phase (1)

Publication Date

2023 (13)
2022 (11)
2021 (11)
2016 (8)
2025 (8)
2024 (8)
2006 (5)
2012 (4)
2026 (4)
2014 (3)
2013 (3)
2010 (3)
2020 (3)
2019 (3)
2018 (3)
2015 (2)
2005 (1)
2011 (1)
2009 (1)

CHEBI ID

CHEBI:28842 (3)
CHEBI:16865 (3)
CHEBI:15741 (3)
CHEBI:15756 (3)
CHEBI:17351 (3)
CHEBI:27432 (3)
CHEBI:9047 (2)
CHEBI:19475 (2)
CHEBI:81321 (2)
CHEBI:32389 (2)
CHEBI:28260 (2)
CHEBI:131740 (2)
CHEBI:28931 (2)
CHEBI:17992 (2)
CHEBI:28757 (2)
CHEBI:16708 (2)
CHEBI:15963 (2)
CHEBI:28044 (2)
CHEBI:16704 (2)
CHEBI:73134 (2)
CHEBI:72998 (2)
CHEBI:131739 (2)
CHEBI:64489 (2)
CHEBI:17750 (2)
CHEBI:36313 (2)
CHEBI:17533 (2)
CHEBI:18183 (2)
CHEBI:6650 (2)
CHEBI:16196 (2)
CHEBI:17509 (2)

Metabolite Name

Uracil (2)
Betaine (2)
Nicotinate (2)
Adenosine (2)
Succinate (2)
Adenine (2)
Guanosine (2)
Uridine (2)
Inosine (2)
Neg_9.75_263.983 (1)
Neg_9.74_728.246 (1)
Neg_9.71_269.99 (1)
Neg_9.7_314.245 (1)
Neg_9.69_330.24 (1)
Neg_9.68_358.1 (1)
Neg_9.68_290.112 (1)
Neg_9.68_222.125 (1)
Neg_9.67_398.227 (1)
Neg_9.58_222.089 (1)
Neg_9.51_388.293 (1)
Neg_9.45_330.24 (1)
Neg_9.24_862.252 (1)
Neg_9.22_445.982 (1)
Neg_9.22_433.983 (1)
Neg_9.22_429.972 (1)
Neg_9.22_363.979 (1)
Neg_9.22_295.993 (1)
Neg_9.22_249.983 (1)
Neg_9.03_230.151 (1)
Neg_8_610.128 (1)

IsPrivate

False (1)

Modelling Approach

Ordinary differential equation model (1)

Study type

Transcription profiling by array (17)
RNA-seq of coding RNA (5)
Methylation profiling by high throughput sequencing (2)
RNA-seq of non coding RNA (2)
RNA-seq of total RNA (1)

Release Date

2025 (337)
2022 (270)
2024 (250)
2023 (231)
2021 (187)
2020 (138)
2019 (74)
2018 (73)
2016 (66)
2017 (60)
2015 (52)
2014 (44)
2026 (42)
2012 (23)
2013 (22)
2010 (10)
2011 (8)
2009 (5)
2006 (5)
2008 (5)
2005 (2)
2007 (1)
2004 (1)
2002 (1)

Lab affiliation

Division of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (2)
Huazhong Agricultural University (2)
Zhejiang Provincial Key Laboratory of Medical Genetics, Key Laboratory of Laboratory Medicine, Ministry of Education, China, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University (2)
1. School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China. 2. Centre for Translational Stem Cell Biology, The University of Hong Kong, Hong Kong Special Administrative Region, China. (1)
Beijing Traditional Chinese Veterinary Engineering Center and Beijing Key Laboratory of Traditional Chinese Veterinary Medicine, Beijing University of Agriculture, No.7 Beinong Road, Changping, Beijing 102206, China. (1)
China Pharmaceutical University (1)
Clinical Medical Research Center, The Second Clinical Medical College of Jinan University (Shenzhen People’s Hospital), Shenzhen, Guangdong;Department of Nephrology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong (1)
Department of Biochemistry & Molecular Biology, New Jersey Medical School of Rutgers University [1] Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai [2] (1)
Department of Chemical and Biomolecular Engineering, The Hong Kong University of Science and Technology (1)
Department of Chemistry, The University of Hong Kong (1)
Department of Ecology, Research Center for Hydrobiology, Jinan University, Guangzhou 510632, People’s Republic of China (1)
Department of Medicine, Columbia University Irving Medical Center (1)
Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA, USA (1)
Department of Nephrology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China;Guangdong-Hong Kong Joint Laboratory on Immunological and Genetic Kidney Diseases; Guangzhou, China. (1)
Department of Rheumatology and Immunology, Shenzhen people's hospital (1)
Department of Rheumatology and Immunology, Shenzhen people's hospital, (1)
Hong Kong Baptist University (1)
Institute of Biophysics, Chinese Academy of Sciences (1)
Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, Shaanxi Province, China. (1)
Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK. UCL Cancer Institute, University College London, London, United Kingdom. Cancer Research UK City of London Centre. GSK (1)
SIMM (1)
School of Life Sciences, The Chinese University of Hong Kong (1)
State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen 361102, Fujian Province, P. R. China (1)
State Key Laboratory of Synthetic Chemistry and Department of Chemistry, The University of Hong Kong, Pokfulam Road, Hong Kong, China (1)
The First Affiliated Hospital of Southern University of Science and Technology, the Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen 518020, China (1)
The Hong Kong University of Science and Technology (1)
Wuhan University (1)

Previous page
1 / 198
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 198
Next page

Sort by:

Relevance

Page size

Pilot Study of Pollution Characteristics and Ecological Risk of Disinfection Byproducts in Natural Waters in Hong Kong.

Not available

S-EPMC9353341 | biostudies-literature

Molecular epidemiology and clinical impact of Klebsiella spp. causing bloodstream infections in Hong Kong.

Not available

S-EPMC10869758 | biostudies-literature

An Anti-Cancer Gold(III)-Activated Porphyrin Scaffold that Covalently Modifies Protein Cysteine Thiols

Cysteine thiols of many cancer-associated proteins are attractive targets of anti-cancer agents. Herein, we unequivocally demonstrate a distinct thiol-targeting property of gold(III) mesoporphyrin IX dimethyl ester (AuMesoIX) and its anti-cancer activities. While the binding of cysteine thiols with ...

ORGANISM(S): Homo sapiens (Human)

2021-09-08 | PXD016875 | Pride

Gold • porphyrin • ligand reactivity• cysteine thiol conjugation • anti-tumor agents

Unlocking the Interaction Mechanism of CNTs and C-S-H on Enhancing Elastic and Viscoelastic Properties of Alite Paste.

Not available

S-EPMC12520525 | biostudies-literature

Progressive Adaptation of Subtype H6N1 Avian Influenza Virus in Taiwan Enhances Mammalian Infectivity, Pathogenicity, and Transmissibility.

Not available

S-EPMC12115762 | biostudies-literature

Hippocampal PPARδ Overexpression or Activation Represses Stress-Induced Depressive Behaviors and Enhances Neurogenesis.

Not available

S-EPMC4772271 | biostudies-literature